Medpace Holdings Inc vs United States Natural Gas Fund — how do they compare? Medpace Holdings Inc trades at $531.34 (market cap $15.08B), while United States Natural Gas Fund trades at $10.39. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| MEDP | UNG | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Commodities - Energy |
52-Week High | $620.59 | $16.90 |
52-Week Low | $308.88 | $10.15 |
Enterprise Value | $14.55B | — |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
UNG trades at $10.29, down 2.09% in the last session, with technical indicators signaling a bearish trend. The stock shows oversold conditions on short-term RSI readings but faces strong selling pressure from moving averages. Recent news highlights volatility in natural gas futures, with prices influenced by weather forecasts and LNG demand fluctuations. Fundamental data is unavailable, limiting traditional valuation analysis.
The outlook remains cautious due to commodity price dependency and lack of fundamental metrics. Risks include energy market volatility and competition from equity-based natural gas ETFs. Analyst sentiment is mixed, with technicals leaning bearish but potential for short-term rebounds if gas prices stabilize.
Trailing returns across standard periods
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →